Cancer Res 2014 Jan 3;74(2):436-45. Epub 2013 Dec 3.
Authors' Affiliations: INSERM, U848; Institut Gustave Roussy; INSERM, U1015, CBT1017; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris; Université Paris Sud/Paris XI; Le Kremlin Bicêtre; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP; Paris; INSERM, UMR 996, LabEx LERMIT, Clamart, France; Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria; Diamantina Institute; School of Medicine, University of Queensland; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Laboratorio de Vetores Virais, Instituto do Coração, FM-USP, São Paulo, Brazil; and Genomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany.